Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Promethera Biosciences

Promethera Biosciences

ADVERTISEMENT
News and Trends

Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial

Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M…

By Jonathan Smith
December 17, 2019 - 2 minutes
News and Trends

First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials

A stem cell therapy developed by the Belgian company Promethera has improved symptoms, such as…

By Jonathan Smith
April 15, 2019 - 2 minutes
In Depth

How is Biotech Innovating to Treat Hemophilia? Let’s Review

Experts say hemophilia treatment is at a 'precipice of a therapeutic revolution.' From antibodies to…

By Clara Rodríguez Fernández
February 13, 2018 - 7 minutes
In Depth

Regenerating the Body With Stem Cells – Hype or Hope?

When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state…

By Melanie De Almeida
July 11, 2017 - 9 minutes
In Depth

Not to be Underestimated: What’s the Hype around NASH?

Since 2014, investment in Non-Alcoholic SteatoHepatitis (NASH) has taken off with a fervor reminiscent of…

By Evelyn Warner
February 7, 2017 - 10 minutes
News and Trends

“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”

Promethera is collecting cash to fuel its liver disease program that revolves around HepaStem. I…

By Evelyn Warner
November 21, 2016 - 7 minutes
News and Trends

Infographic: The Anatomy of European Biotech

Which part of our body do European biotechs prefer to target? And how diversified are…

By Nicolas Sainte-Foie
December 10, 2015 - 1 minute
News and Trends

Louvain-la-Neuve: A Belgian temple for success in cell therapy

Artificial three-dimensional tissues to regenerate bones and soft tissues: Novadip Biosciences’ dream is a step…

By Lourdes Riquelme
September 15, 2015 - 2 minutes
News and Trends

Promethera Biosciences Raised €25,33M to Treat Liver Diseases

Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment…

By Julie Lellouche
November 25, 2014 - 2 minutes
News and Trends

Belgian Promethera received approval to start World first Phase IIb/III stem-cell based urea cycle disorders treatment

Promethera is a promising Belgian Biotechnology company developing stem-cell based treatment against liver diseases. It…

By Philip Hemme
October 25, 2014 - 1 minute
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days